CRDO Slides To $215.48 Into Earnings As 85.65x Trailing Multiple Meets A 4.786% Ten-Year

Credo Technology Group (NASDAQ: CRDO) trades $215.48, down $10.71 or 4.73%, after opening at $220.00 against Monday's $226.19 close. The session range is $212.70 to $221.74 on 1,061,497 shares in the first thirty-four minutes.

The company reports first-quarter fiscal 2027 results after the close today.

That is the worst possible macro setup for this specific stock. Beta stands at 3.23 — the highest in the AI connectivity complex — against a tape where Nasdaq 100 futures are down 1.11%, the VanEck Semiconductor ETF (SMH) is off more than 1% with Nvidia, AMD and Micron each down more than 1%, the 10-year Treasury sits at 4.786% and CME FedWatch prices a 25 basis point Federal Reserve hike on September 16 at 66.4%.

A 3.23-beta name carrying an 85.65 trailing price-to-earnings multiple reporting into a global duration shock is the definition of asymmetric event risk.

The stock has already been repriced hard. At $215.48 it sits 30.2% below the 52-week high of $308.67 and has been in a bear market since late August, having fallen more than 24% from its 2026 peak and more than 20% from a late-June high. Market capitalization is $40.18 billion on 186.48 million shares outstanding.

None of that reflects deteriorating fundamentals. Fiscal 2026 revenue came in at $1.34 billion, up 205.68% from $436.78 million. GAAP earnings reached $472.28 million, up 805.04%, with EPS of $2.51 — a 765.5% increase. Non-GAAP net income hit $662 million. Management is guiding fiscal 2027 revenue growth above 80%.

The thesis for this forecast: Credo has grown into its multiple faster than the market has been willing to pay for it, and tonight's print is the reconciliation. Trailing P/E of 85.65 against a forward P/E of 34.86 is a 59% compression baked into consensus estimates. The company must deliver revenue of $465 million to $475 million against its own guidance, with consensus already at $471.71 million and parts of the sell side modeling above $500 million.

Beat and the multiple justifies itself. Miss on gross margin or hedge on the optical ramp, and a 3.23 beta does the rest.

The Q1 FY2027 Bar: $465M To $475M With Consensus At $471.71M

The numbers that land tonight are tightly defined and the bar is high on both sides of the income statement.

Company guidance calls for revenue between $465 million and $475 million. Against the $223.07 million reported in the year-ago quarter, that implies growth of 108% to 113%. Consensus sits at $471.71 million, near the top of the guided range, with an alternative estimate at $470.7 million implying 111% growth.

On earnings, consensus EPS is $1.17, up from $0.52 in the first quarter of fiscal 2026 — a 125% increase. A second estimate puts it at $1.16, implying a 123.1% year-over-year surge, and that number has remained unchanged over the past thirty days.

The margin guidance is where the risk sits. Management guided GAAP gross margin to 66.9% to 68.9% and non-GAAP gross margin to 67% to 69%, with operating expenses of $86 million to $90 million. Fiscal fourth quarter non-GAAP gross margin came in at 68.3%, so the guide implies flat to slightly compressed margin sequentially.

Gross margin is the single most watched line for a company that just completed a $750 million acquisition and is transitioning revenue mix from copper active electrical cables toward optical products. Optics historically carry lower gross margins than SerDes-based copper solutions. If the optical ramp accelerates faster than expected, revenue beats and margin compresses — and the market has to decide which it cares about more.

The historical record favors a beat. Credo has exceeded consensus in each of the trailing four quarters, with an average surprise of 27.4%. Fiscal fourth-quarter revenue of $437.0 million came in $7 million above the $430 million guidance midpoint, up 157% year over year from $170 million, with non-GAAP EPS of $1.16 against roughly $1.03 expected. Net income for that quarter reached $169 million, up 362% from $36.59 million.

The problem with a company that beats by 27.4% on average is that the market prices the beat before it arrives. Parts of the sell side have already moved beyond the guided range, with published work suggesting quarterly revenue could exceed $500 million and full-year consensus showing 86% growth against management's ">80%" framing.

Meeting guidance is not enough. The stock is priced for the beat.

The $600 Million Optical Story Is The Whole Fiscal 2027 Case

Everything that justifies a $40.18 billion market capitalization on $1.34 billion of trailing revenue runs through one number.

Management projects more than $600 million in optical revenue for fiscal 2027, with three product lines each contributing more than $100 million: ZeroFlap optics, silicon photonics photonic integrated circuits, and discrete optical DSPs. That $600 million against fiscal 2026 revenue of $1.34 billion is roughly half of the absolute growth implied by the ">80%" full-year target.

The cadence matters as much as the total. Management has guided to mid-single-digit sequential growth in the first half of fiscal 2027, followed by a stronger second-half acceleration driven by the optical portfolio. Active electrical cables carry the first half; optics carry the second.

That structure creates a specific trap for tonight's print. First-half guidance is intentionally conservative because the optical ramp is back-half weighted. If Credo delivers $475 million and guides the second quarter to mid-single-digit sequential growth — roughly $490 million to $500 million — the Street's above-$500 million models get disappointed even though the company is executing exactly to plan.

The vertical integration story behind the optical push is the strategic substance. Credo completed a $750 million acquisition of DustPhotonics, adding silicon photonics PIC technology and building out an 800G to 3.2T optical stack aimed at hyperscale AI data centers. The deal brought 800G and 1.6T solutions with a roadmap beyond 3.2T.

Owning the photonics layer rather than buying it changes the margin profile and the design-win dynamics. A vertically integrated stack lets Credo bid full optical modules rather than components, and it removes a supply dependency at the exact moment optical interconnect demand is inflecting.

The execution risk is that $750 million was spent on a technology that has not yet shipped at scale into a market where the incumbents are far larger. Silicon photonics manufacturing yield, packaging and qualification cycles are the standard failure points, and none of them show up in a revenue guide until they slip.

Tonight the market gets its first read on whether the optical ramp is on schedule. That commentary matters more than the revenue number.

Product Portfolio: Copper, Optical, PCIe And The Memory Wall

Credo's franchise sits at the physical layer of AI infrastructure, and the portfolio has widened considerably in eighteen months.

The core business is high-speed connectivity for optical and electrical Ethernet and PCIe applications, sold into the United States, Taiwan, Mainland China, Hong Kong and other international markets. The product set spans ZeroFlap active electrical cables and ZeroFlap optical transceivers, OmniConnect memory solutions, retimers and DSPs for optical and copper Ethernet and PCIe, integrated circuits, SerDes chiplets, and SerDes intellectual property licensing.

Active electrical cables built the company. ZeroFlap AECs solve link-flap reliability in dense rack-scale deployments, and that reliability argument is what converted hyperscalers from passive copper and optical alternatives.

The recent product news shows the expansion into adjacent layers. On August 31, Credo announced its Toucan Gen6x16 PCI Express retimer achieved PCI-SIG 6.x retimer compliance at 64.0 GT/s and is now listed on the PCI-SIG Integrators list. PCIe 6.0 compliance at that data rate is a genuine technical milestone and opens the scale-up interconnect market inside the accelerator rack, which is distinct from the scale-out Ethernet market where AECs compete.

The same day, Credo joined the Open CPX MSA organization to support development of interoperable near-package and co-packaged optical interconnects for AI infrastructure. Co-packaged optics is the direction the industry is moving for the highest-bandwidth links, and MSA participation is how a mid-cap supplier stays inside the standard rather than outside it.

Earlier in August, Credo announced plans to contribute its OmniConnect Scale-In interconnect solution to the Open Compute Project to address the memory wall — the gap between compute throughput and memory bandwidth that increasingly constrains AI inference. That is a strategically important placement: inference workloads are growing faster than training, and memory bandwidth is the binding constraint.

Contributing technology to an open standard trades near-term proprietary margin for long-term volume and design-win breadth. It works when the contributor holds the silicon expertise to implement the standard best.

Employee count is 807 against a $40.18 billion market capitalization — roughly $49.8 million of market value per employee, which is the profile of an IP-and-design company rather than a manufacturer.

Valuation: 85.65x Trailing Against 34.86x Forward

The multiple is where the entire argument lives, and the gap between the two figures is the argument itself.

CRDO trades at 85.65 times trailing earnings on EPS of $2.51 and 34.86 times forward estimates. That is a 59% compression embedded in consensus expectations for the next twelve months — the market is already paying for the earnings acceleration that fiscal 2027 is supposed to deliver.

Push the horizon out and the compression continues. On fiscal 2028 estimates the stock has been characterized as trading near 25 times, which for a company forecast to grow revenue at 28% annually over the next three years against a 20% forecast for the US semiconductor industry is not obviously expensive.

That is the bull case in one sentence: a 25x fiscal 2028 multiple on a business compounding above industry growth with a vertically integrated optical stack.

The bear case is equally clean. An 85.65 trailing multiple provides no valuation support if the growth rate decelerates even modestly, and the forward multiple only works if consensus is right. Consensus has fiscal 2027 growth at 86% against management's own ">80%" framing — the Street is above the company, which is the configuration most likely to produce disappointment.

The valuation history shows how violently this repriced. Over the last three years, earnings per share increased 126% annually while the share price rose 115% annually — the stock has actually lagged its own earnings growth over that window. That is unusual for a high-multiple name and it argues the current 85.65x is a residue of a much larger prior multiple compressing toward fundamentals rather than an expansion.

Consensus price target sits at $283.23 across 19 analysts with a Strong Buy rating, implying 31.44% upside from $215.48. Individual targets published over the past two months span $250 to $350, with several at $300, one initiation at $325, and one at $340.

The dispersion between $250 and $350 on the same company is 40%, and it maps almost entirely to different assumptions about optical revenue timing.

No dividend. There is no yield floor beneath this stock. Everything is growth and execution.

Technical Structure: 30.2% Off The High With $212.70 In Play

The chart has been in a confirmed downtrend since late June and today is testing the lows.

The 52-week range runs $86.49 to $308.67 — a 257% spread that captures the full AI connectivity revaluation and its subsequent unwind. At $215.48 the stock sits 149.1% above the low and 30.2% below the high.

The recent sequence is a clean series of lower highs. The stock declined more than 20% from its late-June peak by August 28. Invezz flagged it entering a bear market on August 31 after falling more than 24% from its 2026 high, quoting $232. Monday closed $226.19. Tuesday opened $220.00 and has traded down to $212.70.

That $212.70 session low is the immediate reference. Holding it into the close would mark the first defense in a week. Losing it opens the $200 psychological handle, which the stock has not traded beneath since the summer.

On the upside, the levels are stacked and close. $221.74 is Tuesday's high. $226.19 is Monday's close and the first genuine resistance. Above that, the $232 level flagged on Monday and then the $250 to $260 band that framed August.

A recovery to the $283.23 consensus target requires a 31.44% advance and would need to clear every one of those levels.

The complicating factor is that the technical picture becomes irrelevant at 4:00 p.m. ET. Options positioning ahead of the print has been flagged as elevated, and a 3.23-beta semiconductor reporting a quarter where consensus implies 111% revenue growth does not respect chart levels — it gaps.

The sector context is negative. Credo appeared alongside peers in a group of 18 tech stocks that fell at least 30% during July, and optical and memory names have been under pressure since the summer as the most explosive AI hardware trades hit resistance. SMH is down more than 1% premarket today.

Trading the chart into an earnings print with an implied move this size is not a strategy. It is a coin flip with leverage attached.

Beta 3.23 Into A 4.786% Ten-Year Is The Real Risk

The macro overlay deserves as much weight as the fundamentals, because a 3.23 beta means the market does two-thirds of the work in this stock.

Every major sovereign curve broke to a multi-decade extreme on the same session Credo reports. The US 10-year Treasury reached 4.786%, the highest since January 2025. The 30-year hit levels last seen in 2007. Japan's 10-year struck 3.00% for the first time since 1996. Germany's Bund pushed to 3.3546%, a 2011 high. The 10-year gilt sits at 5.23%.

CME FedWatch prices a September 16 hike at 66.4%, up from 39.6% a week ago, after a Jackson Hole keynote that put PCE inflation at 3.7% year over year and 4.1% annualized over six months.

For a company whose valuation rests on fiscal 2028 earnings — the 25x figure that makes the bull case work — a synchronized global repricing of the discount rate compresses that valuation mechanically. Credo's cash flows are longer-duration than almost anything in the semiconductor index, because the optical ramp that justifies the multiple is a fiscal 2027 and 2028 event.

The sector response confirms it. SMH is off more than 1%. Nvidia, AMD and Micron are each down more than 1%. Nasdaq 100 futures at 29,185.75 are down 1.11% against Dow futures down 0.59% — the growth complex taking more than double the hit of the cyclical complex, which is the signature of a rate shock rather than a growth scare.

There is a genuine offset. The demand driver underneath Credo — AI data center buildout — is being funded by capital that is largely rate-insensitive. Hyperscalers are issuing aggressively to fund compute, and the financing structures now circulating in the market show that architecture adapting rather than stalling. Credo has been named among the preferred ways to play the next phase of AI infrastructure spending on exactly that argument.

The demand is durable. The multiple is not.

That distinction explains how a stock can fall 30.2% from its high while the company guides to more than 80% revenue growth, and it is the single most important thing to understand about tonight's setup.

Insider Selling And The Options Market's Read

Two positioning signals have been flagged into the print and both point the same direction.

Insider selling has been noted alongside options market jitters ahead of earnings. The pattern is not new for this name — key executives have sold meaningful volume during prior periods of strength — but the timing into a quarter where consensus implies 111% revenue growth is a data point rather than an accident.

Insider selling in a stock that has compounded from $86.49 to $308.67 inside twelve months is largely explainable by diversification and scheduled plans. The absence of offsetting insider buying at $215.48, down 30.2% from the high, carries more information than the selling does.

Management confidence is being signaled through a different channel. The company has framed long-term revenue targets publicly and structured CEO performance-based equity awards running through 2031 — a compensation structure that ties the chief executive to multi-year execution rather than to quarterly prints. That is a meaningful commitment mechanism and it argues management believes the optical thesis extends well beyond fiscal 2027.

Options positioning has been elevated across the August 31 to September 3 window, with Credo named among the stocks carrying notable implied earnings moves. For a 3.23-beta semiconductor guiding to more than 100% revenue growth, the implied move is likely to be double digits in either direction.

The historical reaction pattern is instructive and cuts against the bulls. Following the fiscal fourth-quarter report — a quarter that beat guidance by $7 million with 157% revenue growth and non-GAAP EPS of $1.16 against roughly $1.03 — the stock fell 9% to 14% in after-hours trading on investor concerns about margins, spending and AI capital expenditure timing.

That is the template. Credo beat on every headline metric and sold off because the market focused on gross margin trajectory and the sustainability of hyperscaler spending.

The same three concerns are live tonight, and the stock is 30.2% lower than it was then. Whether that lower starting point provides a cushion or simply confirms the de-rating is the question the print answers.

Competition: Astera Labs, Marvell, Broadcom And The Optical Set

Credo competes across two distinct battlegrounds and its position differs sharply between them.

In scale-out Ethernet connectivity, the direct competition is Marvell (MRVL) and Broadcom (AVGO), both of which build optical DSPs and SerDes at far greater scale with entrenched hyperscaler relationships and vastly larger R&D budgets. Credo's defense in that market has been the active electrical cable — a product category where ZeroFlap reliability solved a specific operational problem that the larger suppliers were not addressing with the same focus.

In scale-up and PCIe connectivity, the direct comparison is Astera Labs (ALAB), which built its franchise on PCIe retimers and smart cable modules. Credo's Toucan Gen6x16 retimer achieving PCI-SIG 6.x compliance at 64.0 GT/s puts it directly into that contest with a validated part rather than a roadmap.

In optics, the competition is the module and component complex — Coherent (COHR), Lumentum (LITE), Macom (MTSI) and the silicon photonics efforts inside the larger semiconductor names. The $750 million DustPhotonics acquisition was specifically about not competing with those suppliers as a customer.

The structural advantage Credo holds is focus. With 807 employees it is small enough to design to a specific hyperscaler requirement and ship it inside a product cycle. The structural disadvantage is that every competitor named above is larger, and several are pursuing the same co-packaged optics and memory-wall opportunities Credo just contributed to open standards.

That contribution strategy is the interesting bet. Standardizing OmniConnect Scale-In within the Open Compute Project and joining the Open CPX MSA both trade proprietary lock-in for ecosystem position. A small supplier inside the standard captures more volume than a small supplier outside it — but it also removes the differentiation that supports a 68.3% gross margin.

Sector exposure runs through SMH and SOXX. For anyone comparing valuations, Credo has been characterized as screening inexpensive relative to most AI suppliers levered to interconnect following its decline — a relative-value argument that only works if the interconnect complex holds up.

The July drawdown across the group, where 18 tech names fell at least 30% in a single month, showed how correlated these trades remain.

Fiscal 2026 In Review: Revenue Tripled, Earnings Rose 805%

The base against which tonight's print is measured is extraordinary and worth stating precisely.

Fiscal 2026 revenue came in at $1.34 billion, an increase of 205.68% from $436.78 million. GAAP earnings reached $472.28 million, up 805.04%. GAAP EPS was $2.51, up 765.5%. Non-GAAP net income totaled $662 million.

That is a company that roughly tripled revenue and multiplied earnings ninefold inside a single fiscal year.

The quarterly progression through fiscal 2026 shows the acceleration. Third-quarter guidance was originally $335 million to $345 million; the company revised it to $404 million to $408 million, above the high end of the original range — a guidance raise of roughly 19% mid-quarter. That quarter delivered a 39% profit margin, up from 22% in the prior-year period, with revenue beating estimates by 3.9% and EPS beating by 24%.

Fourth quarter revenue of $437.0 million was up 157% year over year from $170 million and $7 million above the $430 million guidance midpoint, with non-GAAP gross margin at 68.3% and net income of $169 million against $36.59 million.

The margin expansion is the part that matters most for the forward case. Moving from 22% to 39% net margin inside a year, with non-GAAP gross margin at 68.3%, demonstrates genuine operating leverage rather than revenue growth funded by spending.

The consensus revision history shows how fast the Street chased. The fiscal 2026 revenue forecast was raised from $1.19 billion to $1.32 billion at one update, with the EPS estimate unchanged at $2.10 — analysts raising revenue while holding earnings, which implied margin caution that the actual $2.51 GAAP EPS proved wrong.

The consensus price target sat at $208 during that revision window with the share price at $135. Both figures have since been left far behind — the stock reached $308.67 and the target is now $283.23.

That history is the strongest argument for the bulls. Every consensus estimate on this company over the past two years has been too low, and the stock has repeatedly outrun the Street's willingness to model the ramp.

It is also the reason expectations are now high enough to disappoint.

The Three Things That Decide Tonight's Reaction

Strip away the noise and the print resolves on three specific disclosures.

First, gross margin. Guidance is 67% to 69% non-GAAP against 68.3% delivered in the fourth quarter. The mix shift from copper AECs toward optical products structurally pressures gross margin, and the DustPhotonics integration adds cost before it adds contribution. A print at or above 68% with commentary that the optical mix will not dilute margin further is the single most bullish outcome available. A print at 67% with hedged commentary reproduces the fourth-quarter reaction, when the stock fell 9% to 14% after hours on exactly this concern.

Second, the second-quarter guide. Management framed mid-single-digit sequential growth for the first half of fiscal 2027, which from a $470 million base implies roughly $490 million to $500 million. Parts of the sell side are modeling above $500 million already. A guide at $495 million meets management's stated cadence and misses the Street. A guide above $510 million confirms the optical ramp is pulling forward and validates the 86% consensus growth figure.

Third, the optical revenue commentary. The full-year target is more than $600 million with ZeroFlap optics, silicon photonics PICs and discrete optical DSPs each above $100 million. Any specificity on which of those three is tracking ahead or behind determines how the market models the second half. Silicon photonics is the newest and the riskiest — it arrived through acquisition and has the shortest production history.

Operating expenses at $86 million to $90 million is the secondary line. Coming in above that range signals the integration is costing more than planned.

The reaction function is asymmetric. Beating revenue and holding margin produces a relief rally into $232 and then $250. Beating revenue while conceding margin produces a decline through $212.70 toward $200, because the market has already demonstrated it will sell a beat on margin concerns.

At a 3.23 beta with Nasdaq futures down 1.11% and the 10-year at 4.786%, the downside path is faster than the upside one.

Forecast And Verdict: Own The Franchise, Respect The Print

Weighting the evidence produces a clear conclusion and a clear set of levels.

The business case is intact and strengthening. Fiscal 2026 revenue tripled to $1.34 billion with earnings up 805.04% and non-GAAP net income at $662 million. Fiscal 2027 is guided to more than 80% growth with over $600 million of optical revenue across three product lines each above $100 million. The $750 million DustPhotonics acquisition built a vertically integrated 800G to 3.2T optical stack. The Toucan retimer cleared PCI-SIG 6.x compliance at 64.0 GT/s. Revenue is forecast to compound 28% annually over three years against 20% for the US semiconductor industry. Nineteen analysts carry a Strong Buy with a $283.23 consensus target.

The valuation case is the constraint. At 85.65 times trailing earnings, the stock requires the forward compression to 34.86 times — and then to roughly 25 times fiscal 2028 — to actually happen. Consensus at 86% fiscal 2027 growth sits above management's ">80%" framing, and parts of the Street model above $500 million quarterly revenue against a guide of $465 million to $475 million. Expectations are ahead of the company.

The tape case is the immediate risk. Beta at 3.23 into Nasdaq 100 futures down 1.11%, SMH off more than 1%, the 10-year at 4.786% and 66.4% odds of a Federal Reserve hike on September 16 means the market is actively compressing the multiple on exactly this profile of asset.

Verdict into the print: neutral. The setup is a beat that is already priced against a margin line that has burned holders once. The stock fell 9% to 14% after hours following its last report despite beating on every headline metric, and it is 30.2% below its high entering tonight.

Levels to trade. Downside: $212.70 is the session low, $200 is the psychological handle beneath it, and the June consolidation is the next real support. Upside: $221.74 and $226.19 are the first tests, $232 the level flagged Monday, and $250 to $260 the August band.

Verdict after the print, conditional: constructive above $232 on a print that holds 68% non-GAAP gross margin and guides the second quarter above $500 million. Below $200 on a margin concession, wait — a 3.23-beta name in a rate shock does not find a floor on fundamentals alone.

Size for the gap, not for the thesis.

That's TradingNEWS